Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.83
-0.41 (-4.44%)
Jul 13, 2026, 4:00 PM EDT - Market closed

Prothena Corporation Revenue

Prothena Corporation had revenue of $51.08M in the quarter ending March 31, 2026, with 1,706.36% growth. This brings the company's revenue in the last twelve months to $57.94M, down -57.99% year-over-year. In the year 2025, Prothena Corporation had annual revenue of $9.68M, down -92.83%.

Revenue (ttm)
$57.94M
Revenue Growth
-57.99%
P/S Ratio
7.98
Revenue / Employee
$864,776
Employees
67
Market Cap
462.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.68M-125.47M-92.83%
Dec 31, 2024135.16M43.79M47.92%
Dec 31, 202391.37M37.47M69.50%
Dec 31, 202253.91M-146.67M-73.13%
Dec 31, 2021200.58M199.72M23,414.30%
Dec 31, 2020853.00K39.00K4.79%
Dec 31, 2019814.00K-141.00K-14.76%
Dec 31, 2018955.00K-26.56M-96.53%
Dec 31, 201727.52M26.46M2,508.44%
Dec 31, 20161.06M-552.00K-34.35%
Dec 31, 20151.61M-49.25M-96.84%
Dec 31, 201450.85M50.18M7,422.78%
Dec 31, 2013676.00K-1.98M-74.57%
Dec 31, 20122.66M2.15M424.26%
Dec 31, 2011507.00K-736.00K-59.21%
Dec 31, 20101.24M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE180.25M
Sutro Biopharma99.61M
Verastem49.59M
Prelude Therapeutics16.72M
Evommune10.00M
Ovid Therapeutics7.12M
Ocugen4.47M
Artiva Biotherapeutics251.00K
Revenue Rankings